Randomized controlled trials in surgery of the hand: where we are Randomized controlled trials in surgery are harder to conduct than those in medicine. Such trials are even more difficult for uncommon disorders or highly specialized techniques in surgery because of difficulties in enrolling patients and setting standard techniques. Reviews of published randomized controlled trials in hand surgery indicate that most of them were about common hand disorders (Long et al., 2018) and were conducted in Europe. I applaud the authors for undertaking this immensely important task. Findings from these trials have invited our colleagues to base their clinical decisions on more solid evidence and to revise their practices over time.
This topic generally lacks randomized controlled trials. Though some surgical methods are reasonable, given the caveat which follows, some may benefit from such trials. These include a comparison of methods of metacarpophalangeal ulnar collateral reconstruction and the best opposition transfer for thumb hypoplasia; and a comparison of pollicization versus thumb reconstruction for Grade 3 and 4 hypoplastic thumbs (Michael Tonkin, personal communication, 2018) . It should be noted that all congenital conditions suffer from the difficulties of accurate preoperative and postoperative assessments of the young hand and the relevance of measurement parameters, which makes standardization of the trials and outcome assessment more difficult than other hand problems.
In conducting the trials, inclusion criteria and careful stipulation of clinical questions to be addressed are extremely important in order for the reader to apply conclusions to a defined patient group. The calculation of the sample size is also essential in order to avoid type 2 errors (too small samples) or wasted efforts (too large samples). In making conclusions, minimal clinically important differences in outcomes after different treatments should be considered. In introducing a novel clinical treatment, we may need to consider it an obligation to compare the new technique to the standard procedures.
Evidence that may guide our practice has been accumulating consistently. Our colleagues should make full use of findings from available randomized controlled trials. However, to this end, one must also examine the reports of randomized controlled trials closely because each trial has limitations, which should be stated and read in the discussion of each report, and interpretation of findings depends on how thoughtful the authors were in crafting the conclusions and defining the application scope. In editing, I have noted that some well-executed trials have been interpreted in a less than accurate manner, which has twisted the message of a study. Had the reviewers (and/or editors) not been sufficiently Randomized controlled trials connote evidence, not importance, to a specific practice. It is unwise to undermine a well-conducted important report of a clinical case series. The levels of evidence differ between two types of reports, which by no means suggests that any case series are inferior and carry less impact. Clinical innovations are often in the form of a case series at the start, then superiority of one procedure over others is studied with more stringent trials.
The Journal recognizes the importance of wellconducted studies based on patient case series, especially those dealing with innovative procedures or determining treatment outcomes through reviews of large case series over a long period of time. However, the Journal encourages randomized controlled trialsmore broadly, any prospective studies -designed to address clinical concerns or unanswered questions. These prospective studies deliver higher levels of evidence to guide our decisions in practice.
It is a pity that some of the repeatedly proven conclusions have been insufficiently adopted and that current practices of some colleagues are behind the evidence that has been established (Boeckstyns, 2018) . I urge our colleagues to make themselves more thoroughly aware of available evidence, especially level I evidence, and to update their practice based on evidence that is sufficiently concrete to support any revision. While the practice of hand surgery cannot be fully evidence based, we aspire to the development of well-controlled prospective studies on priority topics in our specialty -such as the ones in the examples given above -all of which call for high-level evidence to guide our decision-making.
